In Silico Analysis of the Correlation of KIF2C with Prognosis and Immune Infiltration in Glioma

Figure 6

Evaluation of the correlation of KIF2C expression and clinicopathologic characteristics. (a) KIF2C was differently expressed in multiple histology of gliomas. (b) KIF2C expression had an obviously positive correlation with the advanced grade gliomas. (c) Higher expression of KIF2C was in WHO grade IV samples relative to that in grade III and grade II samples and in WHO grade III samples compared to that in grade II samples. (d) KIF2C was higher in IDH1 wild-type samples than IDH1 mutant glioma samples. (e) KIF2C was higher in 1p/19q noncodel samples than 1p/19q code glioma samples. (f) KIF2C was higher in recurrent samples than primary glioma samples (Figure 8(f)).

(a)

(b)

(c)

(d)

(e)

(f)